Attana AB
About:
Attana’s third generation biosensors are today used to determine specificity.
Website: https://www.attana.com/
Top Investors: Sciety
Description:
Attana’s third generation biosensors are today used to determine specificity, kinetics and affinity -among other binding characteristics- of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria. their technology has been validated by academic institutions, biotech companies and big-pharma across the world.
Total Funding Amount:
605000 EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2002-01-01
Founders:
Teodor Aastrup
Number of Employees:
1-10
Last Funding Date:
2016-10-12
IPO Status:
Public
Industries:
© 2025 bioDAO.ai